Professional Documents
Culture Documents
Daily symptoms
Daily use of short acting beta 2 agonist
Exacerbation more than twice a week
Night time symptoms more than twice a
week
FEV1 or PEF > than 60% but < 80%
PEF variability >30%
Severe persistent asthma
Continual symptoms
Exacerbations limit physical activity
Frequent nighttime symptoms
FEV1 or PEF <60% of predicted value
PEF variability greater than 30%
Pharmacological therapy
Goal
Prevention of
- chronic symptoms
-recurrent exacerbation
-emergency room visits and
hospitalisation
-maintenance of normal lung function and
normal activity
-Avoidance of side effects
Classes of medication
Anti-inflammatory drugs
Most effective
Reduce the inflammation in the airways-both
swelling and secretions
Decrease the frequency of attacks and need
for other drugs
Lower risk of side effect- direct effect+ lower
dose
Fluticasone,budesonide, beclomethasone
Long acting beta-2 agonist
.Bronchodilators
.Last for at least 12 hours
. Control of moderate to severe symptoms
. Prevent nighttime symptoms
.Used on a regular basis with inhaled steroids
. Not to be used as main treatment
.Salmeterol (Serevent)
Leukotriene modifiers